PBH - Prestige Consumer Healthcare Inc.

57.52
-1.160   -2.017%

Share volume: 278,414
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$58.68
-1.16
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
51%
Profitability 38%
Dept financing 46%
Liquidity 59%
Performance 64%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.05%
1 Month
-8.38%
3 Months
-15.07%
6 Months
-9.22%
1 Year
-28.31%
2 Year
-17.59%
Key data
Stock price
$57.52
P/E Ratio 
15.90
DAY RANGE
$57.24 - $59.29
EPS 
$3.81
52 WEEK RANGE
$51.24 - $89.37
52 WEEK CHANGE
-$27.89
MARKET CAP 
2.966 B
YIELD 
N/A
SHARES OUTSTANDING 
47.319 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-07-2025
BETA 
0.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$354,918
AVERAGE 30 VOLUME 
$532,639
Company detail
CEO: Ronald M. Lombardi
Region: US
Website: prestigebrands.com
Employees: 540
IPO year: 2005
Issue type: Common Stock
Market: NYSE
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies.

Recent news